湖北宜化(000422.SZ):目前具備PVC年產能72萬噸,燒鹼年產能69萬噸
格隆匯2月21日丨湖北宜化(000422.SZ)於近期投資者關係活動表示,公司目前具備PVC年產能72萬噸,燒鹼年產能69萬噸。爲優化氯鹼資源配置,盤活存量資產,公司在去年年底已經關停宜昌市猇亭化工園區的氯鹼裝置,並在宜昌市田家河化工園區投資建設湖北宜化氯鹼新能源項目,以承接並擴充燒鹼產能,以液氯和高純鹽酸替代PVC產品,配套園區下遊化工產品,完善田家河煤、磷、鹽化工產業耦合,預計未來將對公司財務狀況和經營成果產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.